SCHEMBL1687971

SCHEMBL1687971

NC1=CCCC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6724092 0.71
SCHEMBL22048031 0.69
SCHEMBL1930706 0.67
SCHEMBL15583185 0.63
SCHEMBL8036365 0.62
SCHEMBL19528602 0.62
SCHEMBL911012 0.62
SCHEMBL2142376 0.62
SCHEMBL4395206 0.62
SCHEMBL790988 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116694585-A Application of ketoamine reductase in synthesizing chiral pramipexole and synthetic method 华侨大学 2023-09-05 CN claimed
CN-113429331-B Chiral hexahydroindole derivative and preparation method thereof 华东师范大学 2022-10-25 CN claimed
WO-2025226831-A1 PURINE COVALENT BASED CDK12 INHIBITORS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2025-10-30 WO disclosed
WO-2024136528-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 솔루스첨단소재 주식회사 2024-06-27 WO disclosed
WO-2024136555-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME 솔루스첨단소재 주식회사 2024-06-27 WO disclosed
CN-117242072-A TYK2 inhibitor and application thereof 苏多生物科学有限公司 2023-12-15 CN disclosed
EP-3792270-B1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO LTD (KR) 2023-12-13 EP disclosed
CN-114728917-B Oxamide derivative, preparation method and medical application thereof 深圳信立泰药业股份有限公司 2023-12-08 CN disclosed
WO-2023223924-A1 GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED OBJECT, AND LAMINATE DIC株式会社 2023-11-23 WO disclosed
WO-2023223923-A1 HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT DIC株式会社 2023-11-23 WO disclosed
EP-4261037-A1 EPOXY RESIN COMPOSITION, CURED PRODUCT THEREOF, AND LAMINATE DIC Corporation (JP) 2023-10-18 EP disclosed
EP-1820798-A1 7-MEMBERED RING COMPOUND, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL USE THEREOF Asubio Pharma Co., Ltd. (JP) 2007-08-22 EP disclosed
WO-2007084413-A2 METHODS FOR TREATING HEPATITIS C PTC THERAPEUTICS, INC. (US) 2007-07-26 WO disclosed
CN-1984906-A Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity JAPAN TOBACCO INC (JP) 2007-06-20 CN disclosed
CN-1882578-A 2, 4-di (hetero) arylaminopyrimidine derivatives as ZAP-70 and/or SYK inhibitors NOVARTIS AG (CH) 2006-12-20 CN disclosed
CN-1768059-A Pyrido 2,3-d pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents HOFFMANN LA ROCHE (CH) 2006-05-03 CN disclosed
CN-1711265-A Novel amino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents HOFFMANN LA ROCHE (CH) 2005-12-21 CN disclosed
WO-2005110996-A1 NOVEL CIS-IMIDAZOLINES F.HOFFMANN-LA ROCHE AG (CH) 2005-11-24 WO disclosed
CN-1122038-C Heterocycle-fused thiazole derivatives YUNJIAN PHARMACEUTICAL CO LTD (KR) 2003-09-24 CN disclosed
WO-1996033972-A1 METHODS FOR SYNTHESIZING DIVERSE COLLECTIONS OF PYRIDINES, PYRIMIDINES, 1,4-DIHYDRO DERIVATIVES THEREOF, AND PIPERIDINE DERIVATIVES GLAXO GROUP LIMITED (GB) 1996-10-31 WO disclosed